Article Correctness Is Author's Responsibility: First in-human study of drug targeting brain inflammation supports further development

The article below may contain offensive and/or incorrect content.

MW189, a small molecule drug candidate, blocks abnormal inflammation in the brain which contributes to injury and disease induced neurological impairments.